TeamHealth has shut down a private merger offer from AmSurg Corp. TeamHealth is a hospital staffing company while AmSurg aids in running clinics and surgery centers, Bloomberg said. This was announced shortly after the latter has announced that it is engaging with TeamHealth on Tuesday, Reuters said. The offer was at USD5.3 billion at USD71.47 per share, of which TeamHealth is quick to retort that the offer is undervalued. It was noted that the offer was at a 36 percent premium of TeamHealth’s closing price on Monday.
Under the terms of the merger offer, the new company will assume the TeamHealth name and will continue to operate from its headquarters in Knoxville, Tennessee, Street Insider reports. Moreover, the Board of Directors will be filled with representatives from both companies, with AmSurg President and Chief Executive Officer Christopher Holden acting as the new CEO.
In a letter addressed to the members of TeamHealth’s Board, Holden said, “We are disappointed to learn that you chose not to engage with us based on what appears to be a very cursory analysis of our specific proposal and key deal terms.”
If the merger happened, the new company will have about 1,200 health-care facilities and 20,000 clinical workers in its stead, Amsurg said.


Z.AI Shares Slide 7% After $5 Billion Fundraising
Bill Gates Warns Governments Are Unprepared for AI Disruption
Hyundai Delays In-House ADAS, Turns to Nvidia
Nvidia Eyes $10 Billion Investment in Anthropic IPO
OpenAI Agents Linked to RubyGems Cyberattack
Samsung Heavy Wins $1.22 Billion LNG Carrier and Tanker Deal
Meta’s AI Shopping Push Grows as Agentic Commerce Remains Below 1%
Nvidia CEO Jensen Huang Expected at Trump-Xi State Dinner
Rosenblatt Starts Nokia at Buy on AI Networking Growth
Qualcomm Gains on $60B Amazon AI Chip Deal
OpenAI Rules Out 2026 IPO as Altman Prioritizes AI Safety
Cathie Wood Backs AI Slowdown as Safety Concerns Grow
Syngenta Files for Hong Kong IPO, Eyes $5 Billion Raise
BHP Port Hedland Wage Dispute Heads to Arbitration
China’s Global Times Slams Anthropic CEO’s AI Slowdown Plan as ‘Cold War’ Strategy
Meta CEO Zuckerberg Backs Independent AI Safety Reviews Over Development Slowdown 



